From left to right, the first column, represented research related to strategies involving the use of cytokines for targeted therapy of glioma, this group included regression, stem cells, multiforme, interleukin-13, efficacy, safety, epidermal growth factor receptor, target, antitumor activity, antibody and chimeric antigen receptor. Here, IL13 is linked to glioma.